Characterization of RNA aptamers that disrupt the RUNX1–CBFβ/DNA complex
暂无分享,去创建一个
[1] L. Roudaia,et al. CBFbeta is critical for AML1-ETO and TEL-AML1 activity. , 2009, Blood.
[2] S. Butcher,et al. DNA mimicry by a high-affinity anti-NF-κB RNA aptamer , 2007, Nucleic acids research.
[3] S. Radford,et al. Production and Characterization of RNA Aptamers Specific for Amyloid Fibril Epitopes , 2007, Journal of Biological Chemistry.
[4] Bruce R Donald,et al. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta. , 2007, Chemistry & biology.
[5] Hua Shi,et al. RNA aptamers directed to discrete functional sites on a single protein structural domain , 2007, Proceedings of the National Academy of Sciences.
[6] M. Ellingham,et al. Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus. , 2006, RNA.
[7] H. Nelson,et al. An RNA aptamer that interferes with the DNA binding of the HSF transcription activator , 2006, Nucleic acids research.
[8] D. Bunka,et al. Aptamers come of age – at last , 2006, Nature Reviews Microbiology.
[9] F. Mikhail,et al. Normal and transforming functions of RUNX1: A perspective , 2006, Journal of cellular physiology.
[10] D. Guyer,et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.
[11] S. R. Himes,et al. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages , 2005, Oncogene.
[12] G. Morgan,et al. c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis , 2005, Oncogene.
[13] Sunjoo Jeong,et al. Inhibition of the DNA binding by the TCF-1 binding RNA aptamer. , 2005, Biochemical and biophysical research communications.
[14] L. D. Croce,et al. Chromatin modifying activity of leukaemia associated fusion proteins. , 2005, Human molecular genetics.
[15] N. Speck,et al. Core-binding factors in hematopoiesis and immune function , 2004, Oncogene.
[16] Jeff Zimmerman,et al. Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Morgan,et al. Epigenetic consequences of AML1–ETO action at the human c‐FMS locus , 2003, The EMBO journal.
[18] L. Cassiday,et al. Having it both ways: transcription factors that bind DNA and RNA. , 2002, Nucleic acids research.
[19] L. Benson,et al. Binding stoichiometry of an RNA aptamer and its transcription factor target. , 2002, Analytical biochemistry.
[20] S. Klußmann,et al. In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] N. Speck. Core binding factor and its role in normal hematopoietic development. , 2001, Current opinion in hematology.
[22] Jerónimo Bravo,et al. The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp , 2001, Nature Structural Biology.
[23] Takashi Kumasaka,et al. Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβ , 2001, Cell.
[24] B. Sullenger,et al. Developing aptamers into therapeutics. , 2000, The Journal of clinical investigation.
[25] Roger L. Williams,et al. Structural basis for the heterodimeric interaction between the acute leukaemia‐associated transcription factors AML1 and CBFβ , 2000, The EMBO journal.
[26] P. Schuck,et al. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.
[27] E. Seto,et al. A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia* , 2000, The Journal of Biological Chemistry.
[28] J. Murray,et al. Secondary Structure Mapping of an RNA Ligand That Has High Affinity for the MetJ Repressor Protein and Interference Modification Analysis of the Protein-RNA Complex* , 1999, The Journal of Biological Chemistry.
[29] D. Tenen,et al. Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 , 1998, Molecular and Cellular Biology.
[30] M. Ohki,et al. Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.
[31] F. Alt,et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. , 1996, Cell.
[32] F. Alt,et al. The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.
[33] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[34] J. Arnold,et al. A general purification procedure for chemically synthesized oligoribonucleotides. , 1994, Analytical biochemistry.
[35] L. Gold,et al. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. , 1992, Journal of molecular biology.
[36] N. Kamada,et al. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. , 1991, Blood.
[37] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[38] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[39] Gerald F. Joyce,et al. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA , 1990, Nature.
[40] L. Cassiday,et al. Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] Arthur J. Rowe,et al. Analytical ultracentrifugation in biochemistry and polymer science , 1992 .
[42] 麻生 博也. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation , 1992 .